Valuation

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Capitalization 1 4,374 3,097 1,980 5,558 4,108 3,555
Enterprise Value (EV) 1 3,101 2,146 1,785 5,072 3,748 2,826
P/E ratio 49.7 x 30.4 x 26.6 x 42.2 x 10.6 x 30.4 x
Yield 0.25% 0.35% 0.31% 0.39% 0.54% 0.64%
Capitalization / Revenue 2.51 x 1.39 x 0.68 x 1.67 x 1.1 x 0.79 x
EV / Revenue 1.78 x 0.96 x 0.61 x 1.52 x 1 x 0.63 x
EV / EBITDA 18.6 x 11.1 x 14.3 x 14.3 x 7.83 x 6.42 x
EV / FCF 24.3 x -24.7 x 63.7 x 15.4 x 21.5 x 7.6 x
FCF Yield 4.12% -4.05% 1.57% 6.49% 4.66% 13.2%
Price to Book 2.83 x 1.9 x 1.99 x 4.48 x 2.41 x 1.86 x
Nbr of stocks (in thousands) 10,773 10,773 8,081 8,618 8,816 9,045
Reference price 2 406.0 287.5 245.0 645.0 466.0 393.0
Announcement Date 31/08/18 30/08/19 31/08/20 31/08/21 31/08/22 31/08/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Net sales 1 1,740 2,236 2,917 3,330 3,745 4,500
EBITDA 1 167 194 125 355 479 440
EBIT 1 153 176 106 331 450 379
Operating Margin 8.79% 7.87% 3.63% 9.94% 12.02% 8.42%
Earnings before Tax (EBT) 1 125 151 103 253 536 250
Net income 1 88 102 79 129 384 116
Net margin 5.06% 4.56% 2.71% 3.87% 10.25% 2.58%
EPS 2 8.169 9.468 9.214 15.28 43.88 12.95
Free Cash Flow 1 127.6 -87 28 329.2 174.6 372
FCF margin 7.33% -3.89% 0.96% 9.89% 4.66% 8.27%
FCF Conversion (EBITDA) 76.42% - 22.4% 92.75% 36.46% 84.55%
FCF Conversion (Net income) 145.03% - 35.44% 255.23% 45.48% 320.69%
Dividend per Share 2 1.000 1.000 0.7500 2.500 2.500 2.500
Announcement Date 31/08/18 30/08/19 31/08/20 31/08/21 31/08/22 31/08/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: May 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 - 1,592 1,702 889 971 1,997 1,128 1,099 2,342 1,313
EBITDA - - - - - - - - - -
EBIT 1 - 180 249 126 92 192 68 22 169 62
Operating Margin - 11.31% 14.63% 14.17% 9.47% 9.61% 6.03% 2% 7.22% 4.72%
Earnings before Tax (EBT) 1 - 127 328 129 103 221 26 44 192 -34
Net income 1 - 65 246 86 57 130 9 21 115 -69
Net margin - 4.08% 14.45% 9.67% 5.87% 6.51% 0.8% 1.91% 4.91% -5.26%
EPS 2 - 7.865 28.42 9.640 6.520 14.74 0.8700 2.410 12.80 -7.670
Dividend per Share - - - - - - - - - -
Announcement Date - 12/01/21 12/01/22 14/04/22 14/10/22 13/01/23 14/04/23 13/10/23 12/01/24 12/04/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1,273 951 195 486 360 729
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 128 -87 28 329 175 372
ROE (net income / shareholders' equity) 4.89% 6.39% 6.28% 12.1% 26.6% 5.95%
ROA (Net income/ Total Assets) 5.23% 5.59% 3.5% 10.8% 10.7% 7.16%
Assets 1 1,682 1,824 2,258 1,198 3,592 1,621
Book Value Per Share 2 143.0 152.0 123.0 144.0 194.0 212.0
Cash Flow per Share 2 118.0 96.70 74.90 101.0 129.0 168.0
Capex 1 5 19 8 13 2 19
Capex / Sales 0.29% 0.85% 0.27% 0.39% 0.05% 0.42%
Announcement Date 31/08/18 30/08/19 31/08/20 31/08/21 31/08/22 31/08/23
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 3645 Stock
  4. Financials Medical Net, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW